Kalaris Therapeutics, Inc.
KLRS
$4.90
-$0.32-6.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7,098.41% | 3,925.04% | -- | -- | -48.28% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -14.48% | 405.98% | -- | -- | 489.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4,459.06% | 3,541.50% | -- | -- | -21.81% |
|
|
|||||
| Total Current Assets | 4,459.06% | 3,541.50% | -- | -- | -21.81% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -59.17% | 370.06% | -- | -- | -- |
| Total Assets | 1,875.59% | 3,198.46% | -- | -- | 84.88% |
|
|
|||||
| Total Accounts Payable | -17.88% | -77.83% | -- | -- | -33.95% |
| Total Accrued Expenses | 278.06% | 739.26% | -- | -- | 114.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 88.26% |
| Total Other Current Liabilities | -- | -- | -- | -- | 88.26% |
| Total Current Liabilities | -60.68% | -55.94% | -- | -- | 526.66% |
|
|
|||||
| Total Current Liabilities | -60.68% | -55.94% | -- | -- | 526.66% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | -- | -- | -- |
| Total Liabilities | -24.41% | -14.25% | -- | -- | 1,340.36% |
|
|
|||||
| Common Stock & APIC | 1,097.33% | 3,621.82% | -- | -- | 739.08% |
| Retained Earnings | -37.27% | -58.67% | -- | -- | -145.94% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 181.57% | 146.84% | -- | -- | -114.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 3.58% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 3.58% |
|
|
|||||
| Total Common Equity | 181.57% | 146.84% | -- | -- | -114.62% |
| Total Preferred Equity | -- | -- | -- | -- | 3.58% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 255.71% | 196.51% | -- | -- | -8,211.49% |
|
|
|||||